HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

475.517

+6.4061.37%

Number of Gainers:24

Number of Losers:25

Number of Flat:2

PE:- -

High:479.862

Open:468.227

Low:465.418

Close:469.111

Volume:368.12M

Turnover:10.79B

Market Cap:2.98T

Float Cap:2.09T

Loading ...

Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities

Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion

Simcere Pharmaceutical - Share Repurchase Period from Aug 21, 2026 Until Next AGM or Earlier if Authority Revoked

THOMSON REUTERS

Simcere Pharmaceutical - to Repurchase Shares in Open Market up to Rmb1,000 Mln

THOMSON REUTERS

Simcere Pharmaceutical - DR. Zhou Will Serve as President

THOMSON REUTERS

Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer

THOMSON REUTERS

Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million

THOMSON REUTERS

China's 3SBio H1 Net Profit Falls on Higher Expenses

3SBio H1 Revenue RMB 4,526 Million

THOMSON REUTERS

KeyMed Biosciences Announces 2026 H1 Results and Business Updates

THOMSON REUTERS

Press Release: Keymed Biosciences Announces 2026 H1 Results and Business Updates

ZYLOXTB Posts 31% Revenue Growth in 2026 Interim Results, Overseas Sales Surge 349%

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

Zylox-Tonbridge FY26 H1 Profit Climbs 47.8% to RMB 179.1 Million; Revenue Rises 31.1% to RMB 632.04 Million

Zylox-Tonbridge Medical Technology H1 Net Income RMB 179.11 Million

THOMSON REUTERS

Jefferies Adjusts China Resources Beer (Holdings)' Price Target to HK$34.70 From HK$37.70, Keeps at Buy

MT Newswires Live

Blue Moon Group's Interim Results Reveal 55.8% Loss Narrowing as Channel and Marketing Reforms Prove Effective

Blue Moon Group Declares Interim Dividend of HKD 0.08 Per Share

Genscript Bio Issues 1.13 Million Shares Upon Exercise of Share Options

Blue Moon FY26 H1 Net Loss Narrows 55.8% to Hk$192.47 Million; Revenue Falls 5.1% to Hk$2.88 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK1583/news?page=26"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":475.51715,"timestamp":1788336485493,"preClose":469.11102,"halted":0,"volume":368124380,"delay":0,"changeRate":0.013656,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":6.406128,"latestTime":"09-02 16:00:00","open":468.22687,"high":479.86185,"low":465.4181,"amount":10792750243.5,"amplitude":0.03079,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"pbRate":2.123393,"peRate":44.857386,"turnoverRate":0.003434,"increases":23,"decrements":25,"flats":1,"marketCap":2976863298400,"floatMarketCap":2091188461088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":479.86185,"amplitude":0.03079,"preClose":469.11102,"low":465.4181,"pbRate":"2.123393","latestPrice":475.51715,"volume":368124380,"delay":0,"open":468.22687,"prevYearClose":503.90085,"prevWeekClose":483.681,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":483.092,"twentyDayClose":476.028,"sixtyDayClose":414.418,"secType":"PLATE","market":"HK","turnoverRate":0.003434,"peRate":44.857386,"marketCap":2976863298400,"floatMarketCap":2091188461088,"timestamp":1788336485493,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":24,"down":25,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:26,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660233392","title":"Simcere Pharmaceutical Files Board, Committee Member List with Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233392","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233392?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:55","pubTimestamp":1787237702,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical files board, committee member list with disclosure responsibilitiesSimcere set out its board and committee memberships in an Aug. 20, 2026 filing.Ren Jinsheng remains chairman, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3jT45Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660380233","title":"Simcere Pharmaceutical Launches Open-Market Share Buyback of up to RMB 1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660380233","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660380233?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:53","pubTimestamp":1787237588,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical launches open-market share buyback of up to RMB 1 billionSimcere launched an open-market share buyback worth up to RMB 1 billion, starting Aug. 21.Program runs until the next an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7G1PZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233806","title":"Simcere Pharmaceutical - Share Repurchase Period from Aug 21, 2026 Until Next AGM or Earlier if Authority Revoked","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233806?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:52","pubTimestamp":1787237521,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0TQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660023387","title":"Simcere Pharmaceutical - to Repurchase Shares in Open Market up to Rmb1,000 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2660023387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660023387?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:52","pubTimestamp":1787237521,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0TQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660803233","title":"Simcere Pharmaceutical - DR. Zhou Will Serve as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2660803233","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660803233?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:51","pubTimestamp":1787237499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1BP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233821","title":"Simcere Pharmaceutical - Ren Jinsheng Will Serve as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233821","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233821?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:51","pubTimestamp":1787237499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233817","title":"Simcere Pharmaceutical Group H1 Revenue RMB 4,580 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233817?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:50","pubTimestamp":1787237405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXR1LBPG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384532","title":"China's 3SBio H1 Net Profit Falls on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384532?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:37","pubTimestamp":1787236626,"startTime":"0","endTime":"0","summary":"China's 3SBio H1 net profit falls on higher expensesOverviewChina biopharmaceutical firm's half-year revenue rose 3.9% yr/yrNet profit attributable to shareholders fell 15.6% yr/yrGross profit increas","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BK4149","IE00BZ08YT58.USD","MADE","LU0124676726.USD","BK1161","01177","BK4567","BK4533","LU0472753341.HKD","LU0057025933.USD","LU0511384066.AUD","LU0289961442.SGD","BK1589","LU0203347892.USD","LU0203345920.USD","BK4585","IE00BZ08YR35.GBP","LU0069063385.USD","CMI","LU2463526074.USD","BK1593","LU0154245673.USD","BK1191","LU0689626769.HKD","BK1521","BK1515","IE000M9KFDE8.USD","BK1583","BK4588","LU0289739343.SGD","01530","LU0154245756.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660591238","title":"3SBio H1 Revenue RMB 4,526 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660591238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660591238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:28","pubTimestamp":1787236090,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX9N116F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","HK0000165453.HKD","BK1593","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427280","title":"KeyMed Biosciences Announces 2026 H1 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427280","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427280?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:10","pubTimestamp":1787235014,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA5MDWKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02162","BK1574","BK1583","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660232280","title":"Press Release: Keymed Biosciences Announces 2026 H1 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660232280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660232280?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:10","pubTimestamp":1787235000,"startTime":"0","endTime":"0","summary":"CHENGDU, China, Aug. 20, 2026 /PRNewswire/ -- On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim results for the six months ended June 30, 2026. Guided by a clear dual-engine d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BD","BK4096","BK1587","PN","BK1574","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114693671","title":"ZYLOXTB Posts 31% Revenue Growth in 2026 Interim Results, Overseas Sales Surge 349%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114693671","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114693671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:51","pubTimestamp":1787233900,"startTime":"0","endTime":"0","summary":"ZYLOXTB (HKEX: 02190) unveiled its interim results for the first half of 2026 on August 20, showcasing robust financial performance. The company recorded operating revenue of RMB 632 million for the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1574","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287767","title":"Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287767","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287767?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233202,"startTime":"0","endTime":"0","summary":"Chinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansionOverviewChina medical device maker's H1 revenue rose 31.1% yr/yr, driven by device sales growthNet profit for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","HK0000165453.HKD","BK1100","BK1585","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","BK1521","BK1589","01177","SG9999015978.USD","BK1593","LU2488822045.USD","IE00BMCWC346.EUR","02190","BK1574","BK1515","BK1583","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","SG9999015945.SGD","SG9999004220.SGD","01696","00656","SG9999015986.USD","IE00BYV24P56.USD","BK1587","IE00BVYPNP33.GBP","BK1191","00867","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287145","title":"Zylox-Tonbridge FY26 H1 Profit Climbs 47.8% to RMB 179.1 Million; Revenue Rises 31.1% to RMB 632.04 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287145","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287145?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:29","pubTimestamp":1787232592,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge FY26 H1 profit climbs 47.8% to RMB 179.1 million; revenue rises 31.1% to RMB 632.04 millionZylox-Tonbridge posted IFRS profit for the period of RMB 179.11 million, up 47.8%, as revenue","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3Qm0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1574","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287130","title":"Zylox-Tonbridge Medical Technology H1 Net Income RMB 179.11 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287130?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:29","pubTimestamp":1787232559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX6FQ377:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1574","02190","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660841932","title":"Jefferies Adjusts China Resources Beer (Holdings)' Price Target to HK$34.70 From HK$37.70, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660841932","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660841932?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:29","pubTimestamp":1787228992,"startTime":"0","endTime":"0","summary":"China Resources Beer (Holdings) (HKG:0291) has an average rating of buy and mean price target of HK$32.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1589","IE0031814852.USD","IE00B031HY20.USD","LU0359202008.SGD","IE00B5MMRT66.SGD","BK1604","LU0359201612.USD","LU1328615791.USD","LU1023057109.AUD","80291","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1578","IE0008368742.USD","00291","LU1769817179.HKD","SG9999006514.SGD","BK1521","IE00B29SXG58.USD","BK1570","BK1510","IE00B0169L03.USD","LU0328353924.USD","IE0008369823.USD","LU1769817096.USD","LU1720050803.USD","CRHKY","BK1583","LU1794554557.SGD","BK1180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138117675","title":"Blue Moon Group's Interim Results Reveal 55.8% Loss Narrowing as Channel and Marketing Reforms Prove Effective","url":"https://stock-news.laohu8.com/highlight/detail?id=1138117675","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138117675?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:16","pubTimestamp":1787228177,"startTime":"0","endTime":"0","summary":"As consumer preferences continue to evolve, BLUE MOON GROUP (06993) has been advancing operational optimization and structural transformation. According to the interim report, the Group generated...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1102","06993","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660281879","title":"Blue Moon Group Declares Interim Dividend of HKD 0.08 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660281879","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660281879?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:51","pubTimestamp":1787226700,"startTime":"0","endTime":"0","summary":"Blue Moon Group declares interim dividend of HKD 0.08 per shareBlue Moon Group declared an interim dividend of HKD 0.08 per share for the six months ended June 30, 2026.Shares trade ex-dividend on Sep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7jZPCp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06993","BK1102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139847926","title":"Genscript Bio Issues 1.13 Million Shares Upon Exercise of Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1139847926","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139847926?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:46","pubTimestamp":1787226375,"startTime":"0","endTime":"0","summary":"Genscript Bio (01548) has announced that on August 20, 2026, it issued 1.129 million shares pursuant to the exercise of share options under the post-listing share option scheme adopted on December 7,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HK0000320223.HKD","BK1576","HK0000320264.USD","HK0000306701.USD","BK1141","HK0000306685.HKD","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660890352","title":"Blue Moon FY26 H1 Net Loss Narrows 55.8% to Hk$192.47 Million; Revenue Falls 5.1% to Hk$2.88 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660890352","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660890352?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:45","pubTimestamp":1787226314,"startTime":"0","endTime":"0","summary":"Blue Moon FY26 H1 net loss narrows 55.8% to HK$192.47 million; revenue falls 5.1% to HK$2.88 billionBlue Moon Group posted revenue of HK$2.88 billion for the six months ended June 30, down 5.1% year o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL14PxjT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06993","BK1583","BK1102"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":28,"pageCount":26,"totalSize":547,"code":"91000000","status":"200"}]}}